Adamas Pharmaceuticals, Inc. Settlement

Claim Deadline: August 28, 2024

Settlement Fund: $4,650,000

Settlement Class

All persons and entities that purchased or otherwise acquired the publicly traded common stock of Adamas, between August 8, 2017 and March 4, 2019, both dates inclusive (the “Settlement Class Period”), and were damaged thereby.

Important Documents

Settlement Status

Preliminarily Approved

Class Period

August 08, 2017 - March 04, 2019

Settlement Hearing Date

August 30, 2024

Opt-Out Deadline

August 09, 2024

Claims Admin

Adamas Securities Litigation
c/o Strategic Claims Services
P.O. Box 230 600 N. Jackson Street, Suite 205
Media, PA 19063

Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.